HATs off: Selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF

Molecular Cell

Volumn 5, Issue 3, 2000, Pages 589-595

  Lau, Ontario D ^a,b   Kundu, Tapas K ^b   Soccio, Raymond E ^b   Ait Si Ali, Slimane ^c   Khalil, Ehab M ^b   Vassilev, Alex ^c   Wolffe, Alan P ^c   Nakatani, Yoshihiro ^c   Roeder, Robert G ^b   Cole, Philip A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE INHIBITOR; ANTINEOPLASTIC AGENT; COENZYME A; COENZYME A CONJUGATE; HISTONE; HISTONE ACETYLTRANSFERASE; PROTEIN P300; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG ACETYLATION; DRUG ANTAGONISM; DRUG CONJUGATION; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; FROG; GENE EXPRESSION REGULATION; IC 50; NONHUMAN; OOCYTE; TRANSCRIPTION REGULATION;

ANIMALIA; ANURA;

EID: 0033714888     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1097-2765(00)80452-9     Document Type: Article

References (27)

1. The CBP co-activator is a histone acetyltransferase
2. Basic analysis of transcription factor binding to nucleosomes
3. Inhibition of histone acetylation by N-[2-(S-Coenzyme A)acetyl] spermidine amide, a multisubstrate analog
4. Kinetic analysis of the catalytic mechanism of serotonin N-acetyltransferase
5. Structure of the histone acetyltransferase Hat1: A paradigm for the GCN5-related N-acetyltransferase superfamily
6. Differential inhibition of histone and polyamine acetylases by multisubstrate analogs
7. Conjunction dysfunction: CBP/p300 in human disease
8. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
9. Acetylation of general transcription factors by histone acetyltransferases: Identification of a major site of acetylation in TFIIE beta
10. A potent inhibitor of the melatonin rhythm enzyme
11. Mechanism-based inhibition of the melatonin rhythm enzyme: Pharmacologic exploitation of active site functional plasticity
12. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
13. p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation
14. Human TFIIIC relieves chromatin-mediated repression of RNA polymerase III transcription and contains an intrinsic histone acetyltransferase activity
15. NF-Y presets chromatin and potentiates acetylation responsive transcription from the Xenopus hsp70 promoter in vivo
16. p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption
17. Linking histone acetylation to transcriptional regulation
18. The transcriptional coactivators p300 and CBP are histone acetyltransferases
19. Coenzyme A metabolism
20. Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide
21. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates
22. Histone acetylation and transcriptional regulatory mechanisms
23. Catalytic mechanism and function of invariant glutamic acid 173 from the histone acetyltransferase GCN5 transcriptional coactivator
24. A mammalian histone deacetylase related to the yeast transcriptional regulator
25. TFIIIC1 acts through a downstream region to stabilize TFIIIC2 binding to RNA polymerase III promoters
26. Crystal structure of a GCN5-related N-acetyltransferase: Serratia marcescens aminoglycoside 3-N-acetyltransferase
27. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A